Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Life Sciences & Biomedicine (15)
- Science & Technology (15)
- Neurosciences & Neurology (4)
- Pediatrics (4)
- Clinical Neurology (3)
-
- Immunology (3)
- Adult (2)
- DISORDERS (2)
- Environmental & Occupational Health (2)
- Neurosciences (2)
- Obstetrics & Gynecology (2)
- PREDICTORS (2)
- PREVALENCE (2)
- Public (2)
- ACTIVATION (1)
- ADEQUACY (1)
- ADOLESCENT ANOREXIA-NERVOSA (1)
- ADULT (1)
- AMERICAN ACADEMY (1)
- APNEA SYNDROME (1)
- APOPTOSIS (1)
- AUTOIMMUNE-DISEASES (1)
- Adaptive immunity (1)
- Adolescent (1)
- Allergy (1)
- Anomalies (1)
- Anorexia (1)
- B cells (1)
- B-LYMPHOCYTE STIMULATOR (1)
- BIRTH-WEIGHT INFANTS (1)
Articles 61 - 67 of 67
Full-Text Articles in Medicine and Health Sciences
Management Of Pediatric Systemic Lupus Erythematosus: Focus On Belimumab, M. Guzman, J. S. Hui-Yuen
Management Of Pediatric Systemic Lupus Erythematosus: Focus On Belimumab, M. Guzman, J. S. Hui-Yuen
Journal Articles
No abstract provided.
Newborn Screening Protocols And Positive Predictive Value For Congenital Adrenal Hyperplasia Vary Across The United States, P. W. Speiser, R. Chawla, M. Chen, A. Diaz-Thomas, C. Finlayson, M. M. Rutter, D. E. Sandberg, K. Shimy, J. Cerise, E. C. Délot, +2 Additional Authors
Newborn Screening Protocols And Positive Predictive Value For Congenital Adrenal Hyperplasia Vary Across The United States, P. W. Speiser, R. Chawla, M. Chen, A. Diaz-Thomas, C. Finlayson, M. M. Rutter, D. E. Sandberg, K. Shimy, J. Cerise, E. C. Délot, +2 Additional Authors
Journal Articles
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Newborn screening for congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency is mandated throughout the US. Filter paper blood specimens are assayed for 17-hydroxyprogesterone (17OHP). Prematurity, low birth weight, or critical illness cause falsely elevated results. The purpose of this report is to highlight differences in protocols among US state laboratories. We circulated a survey to state laboratory directors requesting qualitative and quantitative information about individual screening programs. Qualitative …
Predictors Of Gestational Weight Gain In A Low-Income Hispanic Population: Sociodemographic Characteristics, Health Behaviors, And Psychosocial Stressors, C. D. Dolin, R. S. Gross, A. L. Deierlein, L. T. Berube, M. Katzow, Y. Yaghoubian, S. G. Brubaker, M. J. Messito
Predictors Of Gestational Weight Gain In A Low-Income Hispanic Population: Sociodemographic Characteristics, Health Behaviors, And Psychosocial Stressors, C. D. Dolin, R. S. Gross, A. L. Deierlein, L. T. Berube, M. Katzow, Y. Yaghoubian, S. G. Brubaker, M. J. Messito
Journal Articles
No abstract provided.
Safety And Tolerability Of Manual Push Administration Of Subcutaneous Igpro20 At High Infusion Rates In Patients With Primary Immunodeficiency: Findings From The Manual Push Administration Cohort Of The Hilo Study, J. Cowan, V. R. Bonagura, P. L. Lugar, P. J. Maglione, N. C. Patel, D. C. Vinh, J. H. Hofmann, M. Praus, M. A. Rojavin
Safety And Tolerability Of Manual Push Administration Of Subcutaneous Igpro20 At High Infusion Rates In Patients With Primary Immunodeficiency: Findings From The Manual Push Administration Cohort Of The Hilo Study, J. Cowan, V. R. Bonagura, P. L. Lugar, P. J. Maglione, N. C. Patel, D. C. Vinh, J. H. Hofmann, M. Praus, M. A. Rojavin
Journal Articles
© 2020, The Author(s). Purpose: To evaluate the safety and tolerability of IgPro20 manual push (also known as rapid push) infusions at flow rates of 0.5–2.0 mL/min. Methods: Patients with primary immunodeficiency (PID) with previous experience administering IgPro20 (Hizentra®, CSL Behring, King of Prussia, PA, USA) were enrolled in the Hizentra® Label Optimization (HILO) study (NCT03033745) and assigned to Pump-assisted Volume Cohort, Pump-assisted Flow Rate Cohort, or Manual Push Flow Rate Cohort; this report describes the latter. Patients administered IgPro20 via manual push at 0.5, 1.0, and 2.0 mL/min/site for 4 weeks each. Responder rates (percentage of patients who completed …
Use Of Organ Dysfunction As A Primary Outcome Variable Following Cecal Ligation And Puncture: Recommendations For Future Studies, M. N. Abraham, A. P. Kelly, A. B. Brandwein, T. D. Fernandes, D. E. Leisman, M. D. Taylor, M. R. Brewer, C. A. Capone, C. S. Deutschman
Use Of Organ Dysfunction As A Primary Outcome Variable Following Cecal Ligation And Puncture: Recommendations For Future Studies, M. N. Abraham, A. P. Kelly, A. B. Brandwein, T. D. Fernandes, D. E. Leisman, M. D. Taylor, M. R. Brewer, C. A. Capone, C. S. Deutschman
Journal Articles
Outcomes variables for research on sepsis have centered on mortality and changes in the host immune response. However, a recent task force (Sepsis-3) revised the definition of sepsis to "life-threatening organ dysfunction caused by a dysregulated host response to infection." This new definition suggests that human studies should focus on organ dysfunction. The appropriate criteria for organ dysfunction in either human sepsis or animal models are, however, poorly delineated, limiting the potential for translation. Further, in many systems, the difference between "dysfunction" and "injury" may not be clear. In this review, we identify criteria for organ dysfunction and/or injury in …
Use Of Tetanus Toxoid, Reduced Diphtheria Toxoid, And Acellular Pertussis Vaccines: Updated Recommendations Of The Advisory Committee On Immunization Practices - United States, 2019, F. P. Havers, P. L. Moro, P. Hunter, S. Hariri, H. Bernstein
Use Of Tetanus Toxoid, Reduced Diphtheria Toxoid, And Acellular Pertussis Vaccines: Updated Recommendations Of The Advisory Committee On Immunization Practices - United States, 2019, F. P. Havers, P. L. Moro, P. Hunter, S. Hariri, H. Bernstein
Journal Articles
No abstract provided.
Characteristics And Risk Factors Associated With Critical Illness In Pediatric Covid-19, G. Fisler, S. M. Izard, S. Shah, D. Lewis, M. K. Kainth, S. H. F. Hagmann, J. A. Belfer, L. M. Feld, F. Mastroianni, C. L. Kvasnovsky, C. A. Capone, J. Schneider, T. Sweberg, C. Schleien, M. D. Taylor
Characteristics And Risk Factors Associated With Critical Illness In Pediatric Covid-19, G. Fisler, S. M. Izard, S. Shah, D. Lewis, M. K. Kainth, S. H. F. Hagmann, J. A. Belfer, L. M. Feld, F. Mastroianni, C. L. Kvasnovsky, C. A. Capone, J. Schneider, T. Sweberg, C. Schleien, M. D. Taylor
Journal Articles
© 2020, The Author(s). Background: While much has been reported regarding the clinical course of COVID-19 in children, little is known regarding factors associated with organ dysfunction in pediatric COVID-19. We describe critical illness in pediatric patients with active COVID-19 and identify factors associated with PICU admission and organ dysfunction. This is a retrospective chart review of 77 pediatric patients age 1 day to 21 years admitted to two New York City pediatric hospitals within the Northwell Health system between February 1 and April 24, 2020 with PCR + SARS-CoV-2. Descriptive statistics were used to describe the hospital course and …